300871 回盛生物
交易中 11-05 09:32:15
资讯
新帖
简况
股市必读：回盛生物新发布《关于回购公司股份的进展公告》
证券之星 · 11-03 03:10
股市必读：回盛生物新发布《关于回购公司股份的进展公告》
回盛生物：今年前三季度实现营业收入12.85亿元
证券之星 · 10-29
回盛生物：今年前三季度实现营业收入12.85亿元
回盛生物：新疆生产基地如果顺利投产，有利于公司将技术创新与当地能源、原料优势融合，打造合成生物学技术的产业化平台
证券之星 · 10-29
回盛生物：新疆生产基地如果顺利投产，有利于公司将技术创新与当地能源、原料优势融合，打造合成生物学技术的产业化平台
回盛生物：猪周期对公司的影响有所下降
证券之星 · 10-29
回盛生物：猪周期对公司的影响有所下降
股市必读：回盛生物三季报 - 第三季度单季净利润同比下降24.95%
证券之星 · 10-26
股市必读：回盛生物三季报 - 第三季度单季净利润同比下降24.95%
回盛生物(300871)9月30日股东户数1.88万户，较上期减少2.7%
证券之星 · 10-23
回盛生物(300871)9月30日股东户数1.88万户，较上期减少2.7%
10月23日回盛生物现1笔折价16.09%的大宗交易 合计成交3300.03万元
证券之星 · 10-23
10月23日回盛生物现1笔折价16.09%的大宗交易 合计成交3300.03万元
回盛生物：泰乐菌素、泰万菌素原料药价格均处于历史较低位置
格隆汇 · 10-23
回盛生物：泰乐菌素、泰万菌素原料药价格均处于历史较低位置
股市必读：回盛生物新发布《2026年三季度报告》
证券之星 · 10-23
股市必读：回盛生物新发布《2026年三季度报告》
图解回盛生物三季报：第三季度单季净利润同比下降24.95%
证券之星 · 10-23
图解回盛生物三季报：第三季度单季净利润同比下降24.95%
回盛生物：10月22日接受机构调研，东方财富证券、开源证券等多家机构参与
证券之星 · 10-22
回盛生物：10月22日接受机构调研，东方财富证券、开源证券等多家机构参与
回盛生物（300871）披露控股股东部分股份解除质押公告，10月15日股价下跌3.56%
证券之星 · 10-15
回盛生物（300871）披露控股股东部分股份解除质押公告，10月15日股价下跌3.56%
股市必读：回盛生物（300871）10月13日董秘有最新回复
证券之星 · 10-14
股市必读：回盛生物（300871）10月13日董秘有最新回复
回盛生物：公司已预约2026年10月23日披露三季报
证券之星 · 10-13
回盛生物：公司已预约2026年10月23日披露三季报
回盛生物（300871）披露回购公司股份进展公告，10月09日股价下跌1.6%
证券之星 · 10-09
回盛生物（300871）披露回购公司股份进展公告，10月09日股价下跌1.6%
回盛生物（300871）9月30日主力资金净买入218.36万元
证券之星 · 10-08
回盛生物（300871）9月30日主力资金净买入218.36万元
回盛生物（300871）披露控股股东部分股份质押公告，9月30日股价上涨2.33%
证券之星 · 09-30
回盛生物（300871）披露控股股东部分股份质押公告，9月30日股价上涨2.33%
回盛生物（300871）披露控股股东向实际控制人内部转让股份计划，9月10日股价下跌3.36%
证券之星 · 09-10
回盛生物（300871）披露控股股东向实际控制人内部转让股份计划，9月10日股价下跌3.36%
回盛生物（300871）披露回购公司股份进展公告，9月1日股价上涨2.45%
证券之星 · 09-01
回盛生物（300871）披露回购公司股份进展公告，9月1日股价上涨2.45%
股市必读：回盛生物新发布《2026年半年度权益分派实施公告》
证券之星 · 09-01
股市必读：回盛生物新发布《2026年半年度权益分派实施公告》
加载更多
公司概况
公司名称：
武汉回盛生物科技股份有限公司
所属行业：
医药制造业
上市日期：
2020-08-24
主营业务：
武汉回盛生物科技股份有限公司的主营业务是兽用药品(包括化药制剂、原料药、中药制剂)、饲料及添加剂的研发、生产和销售。公司的主要产品是兽用药品（包括化药制剂、原料药、中药制剂）、饲料及添加剂。公司是农业产业化国家重点龙头企业。
发行价格：
33.61
{"stockData":{"symbol":"300871","market":"SZ","secType":"STK","nameCN":"回盛生物","latestPrice":17.35,"timestamp":1793842335000,"preClose":17.25,"halted":0,"volume":252300,"delay":0,"changeRate":0.0058,"floatShares":202000000,"shares":202000000,"eps":1.6062,"marketStatus":"交易中","change":0.1,"latestTime":"11-05 09:32:15","open":17.2,"high":17.42,"low":17.18,"amount":4362800,"amplitude":0.0139,"askPrice":17.35,"askSize":296,"bidPrice":17.31,"bidSize":66,"shortable":0,"etf":0,"ttmEps":1.6062,"tradingStatus":2,"nextMarketStatus":{"tag":"午间休市","tradingStatus":4,"beginTime":1793849400000},"marketStatusCode":2,"adr":0,"adjPreClose":17.25,"symbolType":"stock","openAndCloseTimeList":[[1793842200000,1793849400000],[1793854800000,1793862000000]],"highLimit":18.98,"lowLimit":15.53,"ibTradeSell":false,"ibTradeBuySell":false,"totalEquity":201784357,"isCdr":false,"pbRate":1.51,"roa":"--","peRate":10.801893,"roe":"11.37%","epsLYR":1.3349,"committee":-0.592437,"marketValue":3501000000,"turnoverRate":0.0013,"status":0,"floatMarketCap":3501000000},"requestUrl":"/m/hq/s/300871","defaultTab":"news","newsList":[{"id":"2680604767","title":"股市必读：回盛生物新发布《关于回购公司股份的进展公告》","url":"https://stock-news.laohu8.com/highlight/detail?id=2680604767","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2680604767?lang=zh_cn&edition=full","pubTime":"2026-11-03 03:10","pubTimestamp":1793646644,"startTime":"0","endTime":"0","summary":"截至2026年11月2日收盘，回盛生物报收于16.91元，上涨1.99%，换手率1.87%，成交量3.77万手，成交额6324.4万元。公司公告汇总：截至10月31日，回盛生物已累计回购股份1,370,900股，占总股本0.68%，耗资30,093,963.00元，回购进展符合方案要求。公司公告汇总关于回购公司股份的进展公告武汉回盛生物科技股份有限公司于2026年6月8日召开董事会，审议通过以集中竞价交易方式回购公司股份的方案，拟用于员工持股计划或股权激励。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026110300005397.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300871","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2679400907","title":"回盛生物：今年前三季度实现营业收入12.85亿元","url":"https://stock-news.laohu8.com/highlight/detail?id=2679400907","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2679400907?lang=zh_cn&edition=full","pubTime":"2026-10-29 20:51","pubTimestamp":1793278305,"startTime":"0","endTime":"0","summary":"证券之星消息，回盛生物10月28日在投资者关系平台上答复投资者关心的问题。公司已披露2026年三季报，今年前三季度实现营业收入12.85亿元，实现归属于上市公司股东的净利润2.59亿元；2026年第三季度，公司实现营业收入4.20亿元，实现归属于上市公司股东的净利润5,307.92万元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026102900058677.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300871"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2679467214","title":"回盛生物：新疆生产基地如果顺利投产，有利于公司将技术创新与当地能源、原料优势融合，打造合成生物学技术的产业化平台","url":"https://stock-news.laohu8.com/highlight/detail?id=2679467214","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2679467214?lang=zh_cn&edition=full","pubTime":"2026-10-29 08:48","pubTimestamp":1793234898,"startTime":"0","endTime":"0","summary":"投资者提问：1.据报道，公司新疆项目预计12月正式投产，比原计划提前接近一半时间，公司着急释放产能是因为什么原因？目前，公司新疆项目进展顺利，具体投产时间以公司披露口径为准。近几年公司在微生物发酵领域取得了较大的技术创新、积累了较为丰富的生产经验。新疆生产基地如果顺利投产，有利于公司将技术创新与当地能源、原料优势融合，打造合成生物学技术的产业化平台。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026102900015168.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","300871","159945"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2679460184","title":"回盛生物：猪周期对公司的影响有所下降","url":"https://stock-news.laohu8.com/highlight/detail?id=2679460184","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2679460184?lang=zh_cn&edition=full","pubTime":"2026-10-29 08:45","pubTimestamp":1793234714,"startTime":"0","endTime":"0","summary":"证券之星消息，回盛生物10月28日在投资者关系平台上答复投资者关心的问题。公司锚定“科技创新、业务转型、产业布局”三大发展策略，聚焦前沿科技创新、做深做宽“原料-制剂一体化”、大力开拓海外市场、积极培育宠物健康业务，猪周期对公司的影响有所下降，在生猪养殖行情低迷的背景下，今年前三季度公司经营业绩仍实现增长。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026102900015095.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300871","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2678613983","title":"股市必读：回盛生物三季报 - 第三季度单季净利润同比下降24.95%","url":"https://stock-news.laohu8.com/highlight/detail?id=2678613983","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2678613983?lang=zh_cn&edition=full","pubTime":"2026-10-26 03:48","pubTimestamp":1792957691,"startTime":"0","endTime":"0","summary":"大宗交易10月23日回盛生物发生1笔大宗交易，折价率16.09%，成交金额3300.03万元。2026年第三季度单季度主营收入4.2亿元，同比下降4.01%；归母净利润5307.92万元，同比下降24.95%；扣非净利润4831.11万元，同比下降27.4%；负债率31.77%，毛利率33.68%。公司公告汇总2026年三季度报告2026年第三季度营业收入419,776,811.60元，同比下降4.01%；归属于上市公司股东的净利润53,079,162.76元，同比下降24.95%。年初至报告期末营业收入1,284,706,901.85元，同比增长2.00%；归属于上市公司股东的净利润258,839,386.25元，同比增长37.75%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026102600000969.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300871"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2677487928","title":"回盛生物(300871)9月30日股东户数1.88万户，较上期减少2.7%","url":"https://stock-news.laohu8.com/highlight/detail?id=2677487928","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2677487928?lang=zh_cn&edition=full","pubTime":"2026-10-23 18:03","pubTimestamp":1792749838,"startTime":"0","endTime":"0","summary":"证券之星消息，近日回盛生物披露，截至2026年9月30日公司股东户数为1.88万户，较6月30日减少521.0户，减幅为2.7%。户均持股数量由上期的1.05万股增加至1.08万股，户均持股市值为22.7万元。在动物保健行业个股中，回盛生物股东户数高于行业平均水平，截至9月30日，动物保健行业平均股东户数为1.87万户。根据统计，回盛生物2026年6月30日至2026年9月30日，主力资金净流出6736.63万元，游资资金净流入916.08万元，散户资金净流入5820.55万元。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026102300033206.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","300871"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2677940509","title":"10月23日回盛生物现1笔折价16.09%的大宗交易 合计成交3300.03万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2677940509","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2677940509?lang=zh_cn&edition=full","pubTime":"2026-10-23 17:39","pubTimestamp":1792748392,"startTime":"0","endTime":"0","summary":"证券之星消息，10月23日回盛生物发生大宗交易，交易数据如下：大宗交易成交价格15.07元，相对当日收盘价折价16.09%，成交218.98万股，成交金额3300.03万元，买方营业部为华泰证券股份有限公司宜昌西陵一路证券营业部，卖方营业部为国泰海通证券股份有限公司武汉光谷证券营业部。近三个月该股共发生1笔大宗交易，合计成交2.19万手，折价成交1笔。截至2026年10月23日收盘，回盛生物报收于17.96元，下跌4.67%，换手率4.25%，成交量8.58万手，成交额1.51亿元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026102300032070.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300871","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2677146569","title":"回盛生物：泰乐菌素、泰万菌素原料药价格均处于历史较低位置","url":"https://stock-news.laohu8.com/highlight/detail?id=2677146569","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2677146569?lang=zh_cn&edition=full","pubTime":"2026-10-23 11:52","pubTimestamp":1792727547,"startTime":"0","endTime":"0","summary":null,"market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["BK0239","300871"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2677993075","title":"股市必读：回盛生物新发布《2026年三季度报告》","url":"https://stock-news.laohu8.com/highlight/detail?id=2677993075","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2677993075?lang=zh_cn&edition=full","pubTime":"2026-10-23 03:08","pubTimestamp":1792696093,"startTime":"0","endTime":"0","summary":"公司公告汇总2026年三季度报告武汉回盛生物科技股份有限公司2026年第三季度营业收入为419,776,811.60元，同比下降4.01%；归属于上市公司股东的净利润为53,079,162.76元，同比下降24.95%。年初至报告期末营业收入为1,284,706,901.85元，同比增长2.00%；归属于上市公司股东的净利润为258,839,386.25元，同比增长37.75%。第四届董事会第十二次会议决议公告武汉回盛生物科技股份有限公司于2026年10月22日召开第四届董事会第十二次会议，审议通过《关于<2026年第三季度报告>的议案》。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026102300002575.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","300871"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2677960450","title":"图解回盛生物三季报：第三季度单季净利润同比下降24.95%","url":"https://stock-news.laohu8.com/highlight/detail?id=2677960450","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2677960450?lang=zh_cn&edition=full","pubTime":"2026-10-23 01:03","pubTimestamp":1792688638,"startTime":"0","endTime":"0","summary":"证券之星消息，回盛生物2026年三季报显示，前三季度公司主营收入12.85亿元，同比上升2.0%；归母净利润2.59亿元，同比上升37.75%；扣非净利润1.91亿元，同比上升14.91%；其中2026年第三季度，公司单季度主营收入4.2亿元，同比下降4.01%；单季度归母净利润5307.92万元，同比下降24.95%；单季度扣非净利润4831.11万元，同比下降27.4%；负债率31.77%，投资收益115.12万元，财务费用466.76万元，毛利率33.68%。财报数据概要请见下图:本文数据来源于回盛生物2026年三季报，仅供参考不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026102300001309.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300871"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2677964473","title":"回盛生物：10月22日接受机构调研，东方财富证券、开源证券等多家机构参与","url":"https://stock-news.laohu8.com/highlight/detail?id=2677964473","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2677964473?lang=zh_cn&edition=full","pubTime":"2026-10-22 23:01","pubTimestamp":1792681265,"startTime":"0","endTime":"0","summary":"回盛生物2026年三季报显示，前三季度公司主营收入12.85亿元，同比上升2.0%；归母净利润2.59亿元，同比上升37.75%；扣非净利润1.91亿元，同比上升14.91%；其中2026年第三季度，公司单季度主营收入4.2亿元，同比下降4.01%；单季度归母净利润5307.92万元，同比下降24.95%；单季度扣非净利润4831.11万元，同比下降27.4%；负债率31.77%，投资收益115.12万元，财务费用466.76万元，毛利率33.68%。以上内容为证券之星据公开信息整理，仅供参考不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026102200043151.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["LU2097828805.USD","LU2495084118.USD","BK0077","LU1997244956.HKD","300059","LU1997245177.USD","LU2097828631.EUR","LU1997245094.SGD","LU2148510915.USD","LU2097828557.USD","LU2580892789.USD","161027","BK0095","BK0239","LU0326950275.SGD","LU1064130708.USD","BK0188","LU1064131003.USD","BK0276","BK0055","BK0028","LU1981816686.USD","LU2097828714.EUR","LU2580892862.HKD","BK0196","SG9999014674.SGD","300871","LU2097828474.EUR","LU2289578879.USD","LU1831875114.USD","BK0201"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2675337705","title":"回盛生物（300871）披露控股股东部分股份解除质押公告，10月15日股价下跌3.56%","url":"https://stock-news.laohu8.com/highlight/detail?id=2675337705","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2675337705?lang=zh_cn&edition=full","pubTime":"2026-10-15 22:38","pubTimestamp":1792075093,"startTime":"0","endTime":"0","summary":"截至2026年10月15日收盘，回盛生物报收于18.96元，较前一交易日下跌3.56%，最新总市值为38.26亿元。该股当日开盘19.46元，最高19.46元，最低18.88元，成交额达6606.55万元，换手率为1.71%。本次解除质押的质权人为湖北银行股份有限公司武汉武昌支行。本次解除质押后，武汉统盛投资有限公司累计质押股份为2,100,000股，占其所持股份比例2.54%，占公司总股本比例1.04%。公司控股股东所持质押股份目前无平仓风险，不会影响公司实际控制权变更。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026101500039810.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","300871"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2675361914","title":"股市必读：回盛生物（300871）10月13日董秘有最新回复","url":"https://stock-news.laohu8.com/highlight/detail?id=2675361914","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2675361914?lang=zh_cn&edition=full","pubTime":"2026-10-14 02:26","pubTimestamp":1791915971,"startTime":"0","endTime":"0","summary":"截至2026年10月13日收盘，回盛生物报收于20.08元，下跌0.25%，换手率1.91%，成交量3.86万手，成交额7638.42万元。董秘最新回复投资者： 张董事长，公司三季报会发预告吗？公司已预约2026年10月23日披露三季报。泰乐菌素和泰万菌素原料价格受多种因素的影响，公司根据市场情况动态调整产品价格。当日关注点交易信息汇总：10月13日主力资金净流出415.87万元，占总成交额5.44%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026101400001856.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300871","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2675080331","title":"回盛生物：公司已预约2026年10月23日披露三季报","url":"https://stock-news.laohu8.com/highlight/detail?id=2675080331","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2675080331?lang=zh_cn&edition=full","pubTime":"2026-10-13 16:18","pubTimestamp":1791879493,"startTime":"0","endTime":"0","summary":"证券之星消息，回盛生物(300871)10月13日在投资者关系平台上答复投资者关心的问题。投资者提问：张董事长，公司三季报会发预告吗？回盛生物回复：尊敬的投资者，您好！公司已预约2026年10月23日披露三季报。谢谢！本文数据来源于深圳证券交易所互动易，仅供参考不构成投资建议。责任编辑：刘浩然","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026101300026207.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","300871"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2674853503","title":"回盛生物（300871）披露回购公司股份进展公告，10月09日股价下跌1.6%","url":"https://stock-news.laohu8.com/highlight/detail?id=2674853503","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2674853503?lang=zh_cn&edition=full","pubTime":"2026-10-09 18:11","pubTimestamp":1791540683,"startTime":"0","endTime":"0","summary":"截至2026年10月9日收盘，回盛生物报收于20.91元，较前一交易日下跌1.6%，最新总市值为42.19亿元。该股当日开盘21.01元，最高21.34元，最低20.4元，成交额达1.22亿元，换手率为2.9%。公司于近日披露《关于回购公司股份的进展公告》。本次回购符合相关法律法规及公司既定方案。后续将继续实施回购并履行信息披露义务。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026100900029464.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","300871"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673404184","title":"回盛生物（300871）9月30日主力资金净买入218.36万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2673404184","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2673404184?lang=zh_cn&edition=full","pubTime":"2026-10-08 09:09","pubTimestamp":1791421797,"startTime":"0","endTime":"0","summary":"证券之星消息，截至2026年9月30日收盘，回盛生物报收于21.1元，上涨2.33%，换手率2.03%，成交量4.09万手，成交额8637.8万元。9月30日的资金流向数据方面，主力资金净流入218.36万元，占总成交额2.53%，游资资金净流出30.42万元，占总成交额0.35%，散户资金净流出187.94万元，占总成交额2.18%。融券方面，融券卖出0.0股，融券偿还200.0股，融券余量8000.0股，融券余额16.88万元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026100800003055.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300871","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671270114","title":"回盛生物（300871）披露控股股东部分股份质押公告，9月30日股价上涨2.33%","url":"https://stock-news.laohu8.com/highlight/detail?id=2671270114","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2671270114?lang=zh_cn&edition=full","pubTime":"2026-09-30 17:35","pubTimestamp":1790760937,"startTime":"0","endTime":"0","summary":"近日，武汉回盛生物科技股份有限公司收到控股股东武汉统盛投资有限公司通知，其持有的公司1,000,000股股份被质押，占其所持股份比例1.21%，占公司总股本比例0.50%，质押用途为银行融资担保，质权人为湖北银行股份有限公司武汉武昌支行。本次质押后，武汉统盛投资有限公司累计质押股份4,100,000股，占其所持股份比例4.95%，占公司总股本比例2.03%。公司控股股东所持质押股份暂无平仓风险，不会影响公司实际控制权稳定。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026093000028145.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","300871"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666456452","title":"回盛生物（300871）披露控股股东向实际控制人内部转让股份计划，9月10日股价下跌3.36%","url":"https://stock-news.laohu8.com/highlight/detail?id=2666456452","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2666456452?lang=zh_cn&edition=full","pubTime":"2026-09-10 17:52","pubTimestamp":1789033952,"startTime":"0","endTime":"0","summary":"截至2026年9月10日收盘，回盛生物报收于21.83元，较前一交易日下跌3.36%，最新总市值为44.05亿元。近日，回盛生物披露《关于控股股东、实际控制人之间内部转让股份计划的预披露公告》。公告显示，公司控股股东武汉统盛投资有限公司持有公司股份82,800,000股，占总股本41.03%。武汉统盛计划自公告披露之日起15个交易日后的3个月内，通过大宗交易方式向公司实际控制人之一余姣娥女士转让不超过4,000,000股，占总股本1.98%。转让价格将根据二级市场交易价格确定。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026091000032237.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","300871"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664505368","title":"回盛生物（300871）披露回购公司股份进展公告，9月1日股价上涨2.45%","url":"https://stock-news.laohu8.com/highlight/detail?id=2664505368","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2664505368?lang=zh_cn&edition=full","pubTime":"2026-09-01 23:13","pubTimestamp":1788275593,"startTime":"0","endTime":"0","summary":"截至2026年9月1日收盘，回盛生物报收于23.41元，较前一交易日上涨2.45%，最新总市值为47.24亿元。该股当日开盘22.81元，最高23.58元，最低22.81元，成交额达1.55亿元，换手率为3.3%。近日，回盛生物发布《关于回购公司股份的进展公告》。公告显示，公司于2026年6月8日召开董事会，审议通过以集中竞价交易方式回购股份的方案，拟用于员工持股计划或股权激励。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026090100043685.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","300871"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664000925","title":"股市必读：回盛生物新发布《2026年半年度权益分派实施公告》","url":"https://stock-news.laohu8.com/highlight/detail?id=2664000925","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2664000925?lang=zh_cn&edition=full","pubTime":"2026-09-01 02:44","pubTimestamp":1788201852,"startTime":"0","endTime":"0","summary":"公司公告汇总：2026年半年度权益分派方案实施，股权登记日为9月7日，除权除息日为9月8日。关于调整回购股份价格上限的公告武汉回盛生物科技股份有限公司因实施2026年半年度权益分派，向全体股东每10股派发现金红利3.00元（含税），回购股份价格上限自2026年9月8日起由37.00元/股调整为36.70元/股；本次调整依据《回购股份报告书》相关规定，结合除权除息因素进行计算，其他回购事项保持不变。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026090100002506.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300871","BK0239"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"ret":0,"serverTime":1793842338183,"stockEarnings":[{"period":"1week","weight":0.028},{"period":"1month","weight":-0.1825},{"period":"3month","weight":-0.2092},{"period":"6month","weight":-0.3146},{"period":"1year","weight":-0.1842},{"period":"ytd","weight":-0.15}],"compareEarnings":[{"period":"1week","weight":0.0013},{"period":"1month","weight":-0.0406},{"period":"3month","weight":-0.0549},{"period":"6month","weight":-0.1181},{"period":"1year","weight":-0.0692},{"period":"ytd","weight":-0.0712}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"武汉回盛生物科技股份有限公司","boardCode":"AI0027","boardName":"医药制造业","stockholders":"18753人(较上一季度减少2.70%)","perCapita":"10760股","listingDate":"2020-08-24","address":"湖北省武汉市东西湖区新沟街道办事处油纱路52号","registeredCapital":"20178万元","survey":" 武汉回盛生物科技股份有限公司的主营业务是兽用药品(包括化药制剂、原料药、中药制剂)、饲料及添加剂的研发、生产和销售。公司的主要产品是兽用药品（包括化药制剂、原料药、中药制剂）、饲料及添加剂。公司是农业产业化国家重点龙头企业。","listedPrice":33.61},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.52.1","shortVersion":"4.52.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"回盛生物(300871)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供回盛生物(300871)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"回盛生物,300871,回盛生物股票,回盛生物股票老虎,回盛生物股票老虎国际,回盛生物行情,回盛生物股票行情,回盛生物股价,回盛生物股市,回盛生物股票价格,回盛生物股票交易,回盛生物股票购买,回盛生物股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"回盛生物(300871)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供回盛生物(300871)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}